Rallybio Corp (RLYB) — Operating Cash Flow
| Fiscal Year | Operating Cash Flow | Change YoY |
|---|---|---|
| 2025 | -$29.81M | +39.5% |
| 2024 | -$49.28M | +18.2% |
| 2023 | -$60.27M | -5.2% |
| 2022 | -$57.28M | -25.8% |
| 2021 | -$45.53M | -106.6% |
| 2020 | -$22.04M | — |
| Fiscal Year | Operating Cash Flow | Change YoY |
|---|---|---|
| 2025 | -$29.81M | +39.5% |
| 2024 | -$49.28M | +18.2% |
| 2023 | -$60.27M | -5.2% |
| 2022 | -$57.28M | -25.8% |
| 2021 | -$45.53M | -106.6% |
| 2020 | -$22.04M | — |